Rani Therapeutics Holdings, Inc. (RANI)

RANI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.87	18.62	3.76	5.86	27.01	117.45
Short-Term Investments	48.52	31.09	23.88	42.68	71.48	-
Cash & Short-Term Investments	53.39	49.71	27.64	48.54	98.48	117.45
Cash Growth	422.62%	79.85%	-43.06%	-50.71%	-16.15%	60.77%
Accounts Receivable	2.04	2.04	0.43	-	-	-
Other Receivables	0.2	-	-	0.2	-	-
Receivables	2.24	2.04	0.43	0.2	-	-
Prepaid Expenses	0.69	1.37	1.18	1.61	1.94	2.14
Restricted Cash	0.2	0.2	0.5	0.5	0.5	-
Total Current Assets	56.52	53.32	29.74	50.85	100.92	119.6
Property, Plant & Equipment	4.07	5.05	6.64	6.82	7.1	4.61
Other Long-Term Assets	0.25	0.25	0.25	0.25	-	-
Total Assets	60.84	58.62	36.63	57.92	108.03	124.21

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.05	0.31	1.36	0.65	1.46	1.08
Accrued Expenses	3.07	3.9	1.79	1.47	1.76	1.43
Current Portion of Long-Term Debt	-	-	15	4.9	-	-
Current Portion of Leases	1.33	1.59	1.46	0.72	1.01	-
Current Unearned Revenue	5.12	6.83	-	-	-	-
Other Current Liabilities	0.07	0.05	0.28	0.25	0.59	0.13
Total Current Liabilities	10.64	12.67	19.89	7.99	4.82	2.64
Long-Term Debt	-	-	9.61	24.48	29.15	-
Long-Term Leases	2.22	2.73	3.64	-	0.06	-
Long-Term Unearned Revenue	-	1.71	-	-	-	-
Total Liabilities	12.86	17.11	33.14	32.47	34.02	2.64

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	186.26	165.58	104.89	85.76	75.84	55.74
Retained Earnings	-147	-132.58	-102.91	-72.89	-38.92	-8.33
Comprehensive Income & Other	-0.03	0	0.01	-0.01	-0.07	-
Total Common Equity	39.23	33.01	1.99	12.87	36.86	47.41
Minority Interest	8.75	8.5	1.5	12.58	37.15	74.16
Shareholders' Equity	47.99	41.51	3.49	25.44	74	121.57
Total Liabilities & Equity	60.84	58.62	36.63	57.92	108.03	124.21

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	3.55	4.32	29.71	30.1	30.21	-
Net Cash (Debt)	49.84	45.39	-2.07	18.44	68.27	117.45
Net Cash Growth	-	-	-	-72.99%	-41.88%	69.52%
Net Cash Per Share	0.36	0.69	-0.07	0.72	2.87	6.01
Filing Date Shares Outstanding	115.42	99.72	33.51	26.04	25.3	24.39
Total Common Shares Outstanding	112.5	97.62	33.43	26.04	25.3	19.71
Working Capital	45.89	40.65	9.85	42.86	96.11	116.96
Book Value Per Share	0.35	0.34	0.06	0.49	1.46	2.41
Tangible Book Value	39.23	33.01	1.99	12.87	36.86	47.41
Tangible Book Value Per Share	0.35	0.34	0.06	0.49	1.46	2.41
Machinery	4.53	4.49	4.4	4.18	2.82	1.78
Construction In Progress	0.09	0.03	0.03	3.9	4.42	3.87
Leasehold Improvements	1.66	1.66	1.66	1.59	1.55	1.23

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error